Literature DB >> 12204491

Task force #3--getting results: who, where, and how? 33rd Bethesda Conference.

Philip A Ades1, Thomas E Kottke, Nancy Houston Miller, John C McGrath, N Burgess Record, Sandra S Record.   

Abstract

Mesh：

Year:  2002        PMID： 12204491     DOI： 10.1016/s0735-1097(02)02084-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  5 in total

1.  Using technology to enhance prevention services for children in primary care.

Authors:  Teresa W Julian; Kelly Kelleher; David A Julian; Deena Chisolm
Journal:  J Prim Prev       Date:  2007-02-06

2.  Community-wide cardiovascular disease prevention programs and health outcomes in a rural county, 1970-2010.

Authors:  N Burgess Record; Daniel K Onion; Roderick E Prior; David C Dixon; Sandra S Record; Fenwick L Fowler; Gerald R Cayer; Christopher I Amos; Thomas A Pearson
Journal:  JAMA       Date:  2015-01-13       Impact factor: 56.272

Review 3.  The Future of Cardiovascular Epidemiology.

Authors:  Ramachandran S Vasan; Emelia J Benjamin
Journal:  Circulation       Date:  2016-06-21       Impact factor: 29.690

4.  The GoodNEWS (Genes, Nutrition, Exercise, Wellness, and Spiritual Growth) Trial: a community-based participatory research (CBPR) trial with African-American church congregations for reducing cardiovascular disease risk factors--recruitment, measurement, and randomization.

Authors:  Mark J DeHaven; Maria A Ramos-Roman; Nora Gimpel; JoAnn Carson; James DeLemos; Sue Pickens; Chris Simmons; Tiffany Powell-Wiley; Kamakki Banks-Richard; Kerem Shuval; Julie Duvahl; Julie Duval; Liyue Tong; Natalie Hsieh; Jenny J Lee
Journal:  Contemp Clin Trials       Date:  2011-06-02       Impact factor: 2.226

5.  Psychosocial stress and cardiovascular disease. Part 3: Clinical and policy implications of research on the transcendental meditation program.

Authors:  Kenneth G Walton; Robert H Schneider; John W Salerno; Sanford I Nidich
Journal:  Behav Med       Date:  2005       Impact factor: 3.879
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.